...
首页> 外文期刊>Systematic Reviews >A systematic review protocol of timing, efficacy and cost effectiveness of upper limb therapy for motor recovery post-stroke
【24h】

A systematic review protocol of timing, efficacy and cost effectiveness of upper limb therapy for motor recovery post-stroke

机译:对中风后运动恢复的上肢治疗的时机,疗效和成本效益的系统评价方案

获取原文
           

摘要

Improving upper limb (UL) motor recovery after stroke represents a major clinical and scientific goal. We aim to complete three systematic reviews to estimate the (1) association between time to start of UL therapy and motor recovery, (2) relative efficacy of different UL therapy approaches post-stroke and (3) cost-effectiveness of UL therapy interventions. We have designed a systematic review protocol to address three systematic review questions that were each registered with PROSPERO. The search will be conducted in MEDLINE, EMBASE, and Cochrane Controlled Register of Trials. We will include randomised controlled trials, non-randomised clinical trials, before-after studies and observational studies of adult stroke survivors with an average stroke onset ?6?months, undergoing hospital-based therapy to improve UL function. Eligible interventions will aim to promote UL functional recovery. Two reviewers will independently screen, select and extract data. Study risk of bias will be appraised using appropriate tools. Clinical measures of motor recovery will be investigated (primary measure Fugl Meyer UL assessment), as well as measures of health-related quality of life (primary measure EQ-5D) and all cost-effectiveness analyses completed. Secondary outcomes include therapy dose (minutes, weeks, repetitions as available) and safety (i.e. adverse events, serious adverse events). A narrative synthesis will describe quality and content of the evidence. If feasible, we will conduct random effects meta-analyses where appropriate. We anticipate the findings of this review will increase our understanding of UL therapy and inform the generation of novel, data-driven hypotheses for future UL therapy research post-stroke. PROSPERO,?http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018019367, http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018111629, http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42018111628.
机译:改善中风后上肢(UL)的运动恢复是一项重要的临床和科学目标。我们旨在完成三个系统的评估,以估计(1)UL治疗开始时间与运动恢复之间的关联;(2)中风后不同UL治疗方法的相对疗效;以及(3)UL治疗干预的成本效益。我们设计了系统的审查协议,以解决三个已在PROSPERO注册的系统审查问题。搜索将在MEDLINE,EMBASE和Cochrane对照试验注册中进行。我们将包括随机对照试验,非随机临床试验,成年卒中幸存者的平均卒中发作<6个月个月的前后研究和观察性研究,这些患者正在接受医院治疗以改善UL功能。合格的干预措施将旨在促进UL功能的恢复。两名审阅者将独立筛选,选择和提取数据。研究偏倚的风险将使用适当的工具进行评估。将研究运动恢复的临床指标(主要指标Fugl Meyer UL评估)以及与健康相关的生活质量指标(主要指标EQ-5D),并完成所有成本效益分析。次要结果包括治疗剂量(分钟,周,可重复)和安全性(即不良事件,严重不良事件)。叙事综合将描述证据的质量和内容。如果可行,我们将在适当情况下进行随机效应荟萃分析。我们预计本次审查的结果将增加我们对UL治疗的理解,并为未来卒中后UL治疗研究提供新颖的,数据驱动的假设。 PROSPERO,http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID = CRD42018019367,http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID = CRD42018111629 ,http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID = CRD42018111628。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号